# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-24-000019
Filing Date
2024-05-02
Accepted
2024-05-02 16:57:48
Documents
114
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bhc-20240331.htm iXBRL | 10-Q | 2141821
2 | EX-10.1 | exhibit101.htm | EX-10.1 | 53989
3 | EX-10.2 | exhibit102.htm | EX-10.2 | 10927
4 | EX-31.1 | exhibit311q12024.htm | EX-31.1 | 10083
5 | EX-31.2 | exhibit312q12024.htm | EX-31.2 | 10163
6 | EX-32.1 | exhibit321q12024.htm | EX-32.1 | 6567
7 | EX-32.2 | exhibit322q12024.htm | EX-32.2 | 6715
13 | GRAPHIC | image_0.jpg | GRAPHIC | 103774
| Complete submission text file | 0000885590-24-000019.txt |  | 12028957

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bhc-20240331.xsd | EX-101.SCH | 96527
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bhc-20240331_cal.xml | EX-101.CAL | 90843
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bhc-20240331_def.xml | EX-101.DEF | 558898
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bhc-20240331_lab.xml | EX-101.LAB | 865437
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bhc-20240331_pre.xml | EX-101.PRE | 733394
118 | EXTRACTED XBRL INSTANCE DOCUMENT | bhc-20240331_htm.xml | XML | 1949127

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 24909428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)